5 research outputs found
Cell Signaling in Neuronal Stem Cells
The defining characteristic of neural stem cells (NSCs) is their ability to multiply through
symmetric divisions and proliferation, and differentiation by asymmetric divisions, thus giving rise
to different types of cells of the central nervous system (CNS). A strict temporal space control of the
NSC differentiation is necessary, because its alterations are associated with neurological dysfunctions
and, in some cases, death. This work reviews the current state of the molecular mechanisms that
regulate the transcription in NSCs, organized according to whether the origin of the stimulus that
triggers the molecular cascade in the CNS is internal (intrinsic factors) or whether it is the result of
the microenvironment that surrounds the CNS (extrinsic factors)
Epigenetic mechanisms and posttranslational Modifications in systemic lupus erythematosus
The complex physiology of eukaryotic cells is regulated through numerous mechanisms,
including epigenetic changes and posttranslational modifications. The wide-ranging diversity of these mechanisms constitutes a way of dynamic regulation of the functionality of proteins, their activity, and their subcellular localization as well as modulation of the di erential expression of genes in response to external and internal stimuli that allow an organism to respond or adapt to accordingly. However, alterations in these mechanisms have been evidenced in several autoimmune diseases, including systemic lupus erythematosus (SLE). The present review aims to provide an approach to the current knowledge of the implications of these mechanisms in SLE pathophysiology
Cell Signaling in Neuronal Stem Cells
The defining characteristic of neural stem cells (NSCs) is their ability to multiply through symmetric divisions and proliferation, and differentiation by asymmetric divisions, thus giving rise to different types of cells of the central nervous system (CNS). A strict temporal space control of the NSC differentiation is necessary, because its alterations are associated with neurological dysfunctions and, in some cases, death. This work reviews the current state of the molecular mechanisms that regulate the transcription in NSCs, organized according to whether the origin of the stimulus that triggers the molecular cascade in the CNS is internal (intrinsic factors) or whether it is the result of the microenvironment that surrounds the CNS (extrinsic factors)
Evaluation of Tacrolimus Combined With Corticosteroids vs Modified Ponticelli Regimen as Treatments for Refractory Primary Membranous Nephropathy
Objective: To evaluate the immunosuppressive treatment response to modified Ponticelli regimen (MPR) and oral
corticosteroid (OC) plus tacrolimus (TAC) in patients with primary membranous nephropathy (PMN).
Methods: Retrospective cohort analytical study. Adults patients (>18 years old) with diagnosis of refractory PMN
(>50% increase in serum creatinine or a level >1.5mg/dl or proteinuria refractory to 6 months of supportive
treatment), proved by renal biopsy and immunofluorescence between 2008 and 2016 from the Nephropathy
Registry of Colombia (NEFRORED©) were included. Immunosuppressive treatment response was evaluated
from baseline to 6 months after the start of therapy.
Results: 128 patients with PMN were included, of which 74 (57%) were female. The most frequent syndromic
diagnosis was nephrotic syndrome 90 (70%), followed by asymptomatic urinary disorders 31 (25%). Chronic
kidney disease manifested concomitantly in 7 (5%) patients. At the end of 6 months, 86 (67%) cases achieved
some degree of remission: 23 (18%) complete response (CR) and 63 (49%) cases with partial response (PR), while
42 (33%) cases did not achieved remission. In the TAC+OC group, CR and PR were seen in 14 (20%) and 33 (47%)
patients, respectively; and 9 (16%) and 30 (51%) patients in the MPR group, respectively. No statistically
significant differences were found when comparing the immunosuppressive treatment response rate with both
treatment groups (p > 0.05).
Conclusions: In the PMN, both immunosuppressive treatments (TAC+OC vs MPR) are comparable. We suggest a
clinical follow-up of the anti-PLA2R/THSD7A titres at 6/12 months to be correlated with renal function in
subsequent studies
Surface-enhanced Raman Spectroscopy in urinalysis of hypertension patients with kidney disease
Abstract Arterial hypertension (AH) is a multifactorial and asymptomatic disease that affects vital organs such as the kidneys and heart. Considering its prevalence and the associated severe health repercussions, hypertension has become a disease of great relevance for public health across the globe. Conventionally, the classification of an individual as hypertensive or non-hypertensive is conducted through ambulatory blood pressure monitoring over a 24-h period. Although this method provides a reliable diagnosis, it has notable limitations, such as additional costs, intolerance experienced by some patients, and interferences derived from physical activities. Moreover, some patients with significant renal impairment may not present proteinuria. Accordingly, alternative methodologies are applied for the classification of individuals as hypertensive or non-hypertensive, such as the detection of metabolites in urine samples through liquid chromatography or mass spectrometry. However, the high cost of these techniques limits their applicability for clinical use. Consequently, an alternative methodology was developed for the detection of molecular patterns in urine collected from hypertension patients. This study generated a direct discrimination model for hypertensive and non-hypertensive individuals through the amplification of Raman signals in urine samples based on gold nanoparticles and supported by chemometric techniques such as partial least squares-discriminant analysis (PLS-DA). Specifically, 162 patient urine samples were used to create a PLS-DA model. These samples included 87 urine samples from patients diagnosed with hypertension and 75 samples from non-hypertensive volunteers. In the AH group, 35 patients were diagnosed with kidney damage and were further classified into a subgroup termed (RAH). The PLS-DA model with 4 latent variables (LV) was used to classify the hypertensive patients with external validation prediction (P) sensitivity of 86.4%, P specificity of 77.8%, and P accuracy of 82.5%. This study demonstrates the ability of surface-enhanced Raman spectroscopy to differentiate between hypertensive and non-hypertensive patients through urine samples, representing a significant advance in the detection and management of AH. Additionally, the same model was then used to discriminate only patients diagnosed with renal damage and controls with a P sensitivity of 100%, P specificity of 77.8%, and P accuracy of 82.5%